Ursodeoxycholic acid treatment in cystic fibrosis-associated liver disease

被引：0
|
作者：
Colombo, C [1 ]
Comi, S [1 ]
Moretti, E [1 ]
机构：
[1] Univ Sassari, Dept Pediat, I-01700 Sassari, Italy
来源：
BIOLOGY OF BILE ACIDS IN HEALTH AND DISEASE | 2001年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：311 / 316
页数：6
相关论文
共 50 条
  • [31] URSODEOXYCHOLIC ACID FOR CYSTIC FIBROSIS RELATED LIVER DISEASE, OUR EXPERIENCE
    Mujtaba, G.
    Greally, P.
    Elnazir, B.
    PEDIATRIC RESEARCH, 2011, 70 : 534 - 534
  • [32] Ursodeoxycholic acid for cystic fibrosis-related liver disease (Review)
    Cheng, Katharine
    Ashby, Deborah
    Smyth, Rosalind L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [33] Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double-mind multicenter trial
    Colombo, C
    Battezzati, PM
    Podda, M
    Bettinardi, N
    Giunta, A
    HEPATOLOGY, 1996, 23 (06) : 1484 - 1490
  • [34] Noncirrhotic Presinusoidal Portal Hypertension Is Common in Cystic Fibrosis-Associated Liver Disease
    Wittes, Peter
    Libbrecht, Louis
    Roskams, Tania
    De Boeck, Kris
    Dupont, Lieven
    Proesmans, Marijke
    Vermeulen, Francois
    Strandvik, Birgitta
    Lindblad, Anders
    Stephenne, Xavier
    Sokal, Etienne
    Gosseye, Serge
    Heye, Sam
    Maleux, Geert
    Aerts, Raymond
    Monbaliu, Diethard
    Pirenne, Jacques
    Hoffman, Ilse
    Nevens, Frederik
    Cassiman, David
    HEPATOLOGY, 2011, 53 (03) : 1064 - 1065
  • [35] Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease
    OBrien, SM
    Campbell, GR
    Burke, AF
    Maguire, OC
    Rowlands, BJ
    FitzGerald, MX
    Hegarty, JE
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (05) : 477 - 483
  • [36] A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease
    Freeman, A. Jay
    Sellers, Zachary M.
    Mazariegos, George
    Kelly, Andrea
    Saiman, Lisa
    Mallory, George
    Ling, Simon C.
    Narkewicz, Michael R.
    Leung, Daniel H.
    LIVER TRANSPLANTATION, 2019, 25 (04) : 640 - 657
  • [37] Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease
    Debray, Dominique
    Kelly, Deirdre
    Houwen, Roderick
    Strandvik, Birgitta
    Colombo, Carla
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 : S29 - S36
  • [38] ORAL BILE-ACIDS IN CYSTIC FIBROSIS-ASSOCIATED LIVER-DISEASE
    COLOMBO, C
    CROSIGNANI, A
    APOSTOLO, MG
    MARZANO, MT
    BETTINARDI, N
    GIUNTA, A
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1994, 87 : 20 - 24
  • [39] A CONTROLLED TRIAL OF URSODEOXYCHOLIC ACID TREATMENT IN CYSTIC FIBROSIS-RELATED LIVER-DISEASE
    OBRIEN, S
    FITZGERALD, MX
    HEGARTY, JE
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1992, 4 (10) : 857 - 863
  • [40] CYSTIC FIBROSIS-ASSOCIATED LIVER DISEASE IN THE UNITED STATES 2010-2014
    Wasuwanich, Paul
    Ingviya, Thammasin
    Karnsakul, Wikrom
    GASTROENTEROLOGY, 2020, 158 (06) : S1388 - S1388
12345